Profile
Mr. Fred Larcombe, CPA, is a Principal at Crimson Partners, Chief Financial Officer at iBIO, Chief Financial Officer, Secretary & Director at Heartland Bridge Capital, Inc., Chief Financial Officer at The Riderwood Group, Inc., and Chief Financial Officer at Heartland Bridge Capital, Inc. (Private Equity).
Mr. Larcombe has served as Chief Financial Officer for: Xenomics, a developer of DNA diagnostic tests; FermaVir Pharmaceuticals, a pharmaceutical development company; MicroDose Technologies, a drug delivery device company; and Genesis Direct, an internet retailer.
He started his professional career with PriceWaterhouseCoopers (PwC).
Mr. Larcombe received his BS in Accounting from Seton Hall University, and is a graduate of the Management Development Program at Harvard Business School.
Frederick Larcombe active positions
Companies | Position | Start |
---|
Former positions of Frederick Larcombe
Companies | Position | End |
---|---|---|
TRIR WELL | Director of Finance/CFO | 2012-10-24 |
IBIO, INC. | Director of Finance/CFO | 2011-05-02 |
Training of Frederick Larcombe
Seton Hall University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
CARDIFF ONCOLOGY, INC. | Health Technology |
IBIO, INC. | Health Technology |
TRIR WELL | Health Technology |
Private companies | 4 |
---|---|
Genesis Direct , Inc. (New Jersey)
Genesis Direct , Inc. (New Jersey) Catalog/Specialty DistributionRetail Trade Genesis Direct is a database-driven specialty retailer. It offers products directly to consumers in targeted niche markets primarily through distinctive, information-rich catalogs, as well as Internet websites and electronic media, including television and radio. The company is headquartered in Secaucus, NJ. | Retail Trade |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
FermaVir Pharmaceuticals LLC
FermaVir Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology FermaVir Pharmaceuticals, Inc. develops pharmaceutical products. The company manufactures compounds for the treatment of varicella zoster virus and chickenpox and human cytomegalovirus. It conducts preclinical trials on FV-100, a prodrug of a compound CF-1743, for the treatment of shingles. FermaVir Pharmaceuticals was founded in December, 2004 and is headquartered in New York City, NY. | Health Technology |
InterCore, Inc.
InterCore, Inc. Computer CommunicationsElectronic Technology InterCore, Inc. engages in the development of real time safety systems and tracking products. Its Driver Alertness Detection System monitors a driver's state of alertness in real time to reduce the risk of road accidents caused by drowsiness and fatigue. The company is headquartered in Largo, FL. | Electronic Technology |
- Stock Market
- Insiders
- Frederick Larcombe